-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Initiates Coverage On Jade Biosciences with Buy Rating, Announces Price Target of $25

Benzinga·01/07/2026 11:39:20
Listen to the news
HC Wainwright & Co. analyst Arthur He initiates coverage on Jade Biosciences (NASDAQ:JBIO) with a Buy rating and announces Price Target of $25.